Constellation Brands did the thing it almost always does: it beat. Reporting fiscal first-quarter results after Monday's close, the company posted adjusted earnings of $3.43 a share, ahead of the roughly $3.19 analysts expected, according to coverage of the release. Look one line up and the story gets more interesting: net sales fell 3.3% to $2.43 billion.

The tension between those two numbers is the whole point. For a decade, Constellation's Mexican beer portfolio was the most dependable growth engine in American alcohol — Modelo Especial passing Bud Light as the country's top-selling beer, Corona throwing off cash, the whole segment seemingly immune to the malaise hammering domestic brewers. This quarter, the engine is running on different fuel.

Beer revenue still rose about 2% to $2.28 billion, but it got there on pricing and shipment timing — shipments were up roughly 1.8% through the quarter — while the number that actually measures how much beer walked out of stores went the other way. Depletions slipped 0.3%, Brewbound reported, and the mix underneath is the tell: Modelo Especial depletions fell 2% and Corona Extra dropped 5%, with the decline only partly offset by smaller, faster-growing labels — Pacifico up 21%, Victoria up 14%, and Mi Campo tequila up 62%.

Put plainly: the two brands that are the franchise are contracting at the register, and Constellation is papering over it with price increases and a longer tail of niche brands. That works for a quarter. It is not the same as demand.

The reasons aren't a mystery, and they're bigger than beer. The company's core consumer skews Hispanic, a cohort that has pulled back on spending amid an aggressive immigration climate and thinning real wages. Layer on the broader forces reshaping the whole grocery perimeter — moderation, the functional-beverage land grab we covered last week, and the appetite-suppressing effect of GLP-1 medications now estimated to have erased billions in food-and-drink volume — and you have a flagship-beer business fighting the current. Management's commentary on the call leaned, predictably, on premiumization and new higher-ABV line extensions to change the subject.

There's a broader signal here worth flagging, because it repeats just hours later on today's calendar. Constellation grew the top line's value while volume softened — price up, cases flat-to-down. General Mills, reporting this morning, told a nearly identical story in packaged food. Two of the most established consumer-staples operators in the country, reporting within a day of each other, both leaning on price and mix to mask stalled volume. That's not a coincidence; it's the shape of the 2026 consumer — buying a little less, paying a little more, and forcing even recession-resistant categories to choose between units and pricing power. Constellation, for now, is choosing pricing power. The depletion line is the reminder that the choice has a cost.